Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 331.50
Bid: 330.00
Ask: 331.50
Change: 6.50 (2.00%)
Spread: 1.50 (0.455%)
Open: 320.00
High: 335.00
Low: 320.00
Prev. Close: 325.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Nov 2020 07:00

RNS Number : 1034F
Volex PLC
12 November 2020
 

12 November 2020

Volex plc

("Volex" or the "Company")

Board Succession and Development

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, today announces changes to its Board. 

Chief Financial Officer

Daren Morris, who initially joined the business in June 2014 as a Non-Executive Director before becoming Chief Financial Officer in September 2014, has today left the Board with immediate effect and will be leaving the business.

Jon Boaden, who joined the business in April 2019, as Deputy Chief Financial Officer, has been promoted to the role of CFO with immediate effect.

Succession planning has been high on the Board's agenda as it seeks to maintain the Company's growth and development.

Jon Boaden emerged as the leading candidate for succession to the role of Chief Financial Officer following a rigorous profiling and search process including the full evaluation of potential internal and external candidates using specialist consultants. He has played a key role in the significant growth and development of the Group's business since joining the business over 18 months ago and has quickly established himself as a well-respected leader within the organisation.

Independent Non-Executive Director

Sir Peter Westmacott has agreed to join the board as an Independent Non-Executive Director and member of the Company's Nominations Committee effective from 12 November 2020.

Sir Peter is a senior British Diplomat who retired from the Foreign and Commonwealth Office in 2016. He brings with him a wealth of experience from a diplomatic career spanning over 40 years which included 14 years as British Ambassador to Turkey, France and the United States. His substantial record, acknowledged by successive Prime Ministers, of policy and business delivery will be a key asset to Volex.

Sir Peter Westmacott's and Jon Boaden's appointments maintain the Company's approach to strong independent governance and oversight. Following the implementation of these changes, the Company's Board will consist of four non-executive directors and two executive directors.

Nat Rothschild, Executive Chairman of Volex, commented:

"I would like to take this opportunity to thank Daren for his contribution to the group over this period and wish him well for the future.

In line with the Board's long-term succession planning, I am very pleased to announce that Jon Boaden, who joined the business over 18 months ago, will be stepping up to the role of Chief Financial Officer and look forward to working with him in this capacity. Furthermore, I am delighted that we are able to appoint somebody of the calibre of Sir Peter Westmacott as an Independent Non-Executive Director and have no doubt that he will be an invaluable addition to the Board.

Both Jon and Sir Peter's appointments demonstrate the continued evolution of Volex as we look to build on the strong momentum we have generated in recent years."

 

Additional Disclosures Required under the AIM Rules for Companies

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

Jonathan William Boaden, aged 41 years, does not hold any current directorships. Additionally, he has not held any other directorships or partnerships in the last five years. Sir Peter John Westmacott, aged 69 years, holds or has held the following directorships and partnerships in the last five years:

Current Directorships/Partnerships

Former Directorships/Partnerships

Glasswall Holdings Limited

Tellus Matrix LLP

We Soda Limited

EY LLP

Sir Peter is a member of the Ernst and Young UK Independent Non-Executive Oversight Committee.

Save as set out above there are no further disclosures pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of their appointments.

-ENDS-

 

For further information please contact:

Volex plc

+44 (0)7747 488 785

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

Iqra Amin

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Powerscourt - Media Enquiries

 

+44 (0)20 7250 1446

James White

Jack Holden

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMMMVZMGGZG
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20245:13 pmRNSDirector/PDMR Shareholding
16th Jan 202412:33 pmRNSDirector/PDMR Shareholding
10th Jan 20244:45 pmRNSIssue of Equity
22nd Dec 202311:00 amRNSDirector/PDMR Shareholding
7th Dec 20233:42 pmRNSScrip Reference Price
23rd Nov 20237:00 amRNSHalf-year report
8th Nov 20237:15 amRNSAnalyst Briefing & Investor Presentation
24th Oct 20237:00 amRNSUpdate on H1 Trading and Cyber Incident
20th Oct 20237:00 amRNSDirectorate Changes
9th Oct 20237:00 amRNSNotice of Cyber Incident
28th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSCompletion of Murat Ticaret Acquisition
30th Aug 20235:00 pmRNSDirector/PDMR Shareholding
21st Aug 20234:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20237:00 amRNSReceipt of Competition Clearance for Murat Ticaret
27th Jul 20236:23 pmRNSResult of AGM
27th Jul 202311:37 amRNSScrip Reference Price
27th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20234:40 pmRNSDirector/PDMR Shareholding
28th Jun 20234:59 pmRNSHolding(s) in Company
27th Jun 202310:00 amRNSNotice of AGM and Publication of Annual Report
22nd Jun 20231:00 pmRNSResults of Fundraising
22nd Jun 20237:02 amRNSREX Retail Offer
22nd Jun 20237:01 amRNSAcquisition of Murat Ticaret and Proposed Placing
22nd Jun 20237:00 amRNSPreliminary Group Results FY2023
12th Jun 20237:00 amRNSNotice of Results and Investor Presentation
18th May 20237:00 amRNSChange of Adviser
27th Apr 20237:00 amRNSEV Contract Win
18th Apr 20237:00 amRNSFull Year Trading Update
18th Jan 20237:00 amRNSAnalyst Site Visit
22nd Dec 202210:03 amRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20227:00 amRNSScrip Reference Price
9th Nov 20227:00 amRNSHalf-year Report of Volex plc
13th Oct 20227:00 amRNSNotice of Half Year Results
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20223:58 pmRNSDirector / PDMR Dealing
30th Aug 20223:36 pmRNSDirector / PDMR Dealing
19th Aug 20225:32 pmRNSResults of AGM, Issue of Equity and TVR
19th Aug 20227:00 amRNSAGM Statement
29th Jul 20224:00 pmRNSScrip Dividend Scheme and Scrip Reference Price
11th Jul 202210:53 amRNSNotice of AGM and Publication of Annual Report
29th Jun 20225:08 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSPreliminary Group Results FY2022
8th Jun 20227:00 amRNSNotice of Preliminary Results & IMC Presentation
19th May 20227:00 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.